Edgewell Personal Care (EPC) director receives 7,817 restricted units

Rhea-AI Filing Summary

Edgewell Personal Care director Carla C. Hendra received 7,817 restricted stock equivalents on February 5, 2026. These derivative awards carry a stated price of $0 per unit and are held directly. They are designed to convert into shares of Edgewell common stock on a future date.

The restricted stock equivalents convert into common shares on the day before the next annual shareholder meeting, unless the director chooses to defer conversion until service on the Board of Directors ends. After this grant, 7,817 derivative securities are beneficially owned.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hendra Carla C

(Last) (First) (Middle)

C/O EDGEWELL PERSONAL CARE COMPANY

6 RESEARCH DRIVE

(Street)

SHELTON CT 06484

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EDGEWELL PERSONAL CARE Co [ EPC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Equivalents 2-5-2026	$0	02/05/2026		A		7,817		(1)	(1)	Common Stock	7,817	$0	7,817	D

Explanation of Responses:

1. Restricted stock equivalents convert into shares of Edgewell common stock on the day preceding the next annual meeting of shareholders unless the Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors.

	/s/ LaTanya Langley	02/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Edgewell Personal Care (EPC) report for February 5, 2026?

Edgewell Personal Care reported that director Carla C. Hendra received 7,817 restricted stock equivalents on February 5, 2026. These derivative awards were granted at a stated price of $0 per unit and are held directly following the reported transaction.

How many Edgewell Personal Care restricted stock equivalents were granted to Carla C. Hendra?

Carla C. Hendra was granted 7,817 restricted stock equivalents linked to Edgewell Personal Care common stock. These are derivative securities that convert into common shares under specified conditions, and she beneficially owns 7,817 such derivative securities after the reported grant.

When do the restricted stock equivalents for Edgewell director Carla C. Hendra convert into common stock?

The restricted stock equivalents convert into Edgewell common stock on the day preceding the next annual meeting of shareholders. However, the reporting person can elect to defer this conversion until their service on Edgewell’s Board of Directors terminates, extending the timing of share delivery.

What flexibility does Carla C. Hendra have regarding conversion of her Edgewell restricted stock equivalents?

Carla C. Hendra may either allow her restricted stock equivalents to convert into Edgewell common stock on the day before the next annual shareholder meeting or elect to defer conversion. If she defers, conversion occurs when her service on the Board of Directors ends.

How many Edgewell derivative securities does Carla C. Hendra beneficially own after this transaction?

After the reported grant, Carla C. Hendra beneficially owns 7,817 derivative securities in the form of restricted stock equivalents. These are held directly and are designed to convert into Edgewell common stock according to the timing rules tied to shareholder meetings and board service.